tiprankstipranks
Trending News
More News >
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Technical Analysis

Compare
548 Followers

Technical Sentiment

Overall Consensus
Neutral
8Bullish
5Neutral
9Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Athira Pharma’s (ATHA) Moving Averages Convergence Divergence (MACD) indicator is -0.02, suggesting Athira Pharma is a Sell.
Athira Pharma’s (ATHA) 20-Day exponential moving average is 0.27, while Athira Pharma’s (ATHA) share price is $0.29, making it a Buy.
Athira Pharma’s (ATHA) 50-Day exponential moving average is 0.34, while Athira Pharma’s (ATHA) share price is $0.29, making it a Sell.

Athira Pharma (ATHA) Pivot Points

Apr 25, 2025, 12:35 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.21
0.23
0.25
0.26
0.28
0.30
0.32
Fibonacci
0.23
0.24
0.25
0.26
0.28
0.28
0.30
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Athira Pharma (ATHA) Moving Averages

Apr 25, 2025, 12:35 AM
Period
Simple
Exponential
MA5
0.26Buy
0.27Buy
MA10
0.25Buy
0.26Buy
MA20
0.26Buy
0.27Buy
MA50
0.33Sell
0.34Sell
MA100
0.45Sell
0.50Sell
MA200
1.03Sell
1.07Sell
Athira Pharma’s (ATHA) 10-Day exponential moving average is 0.26, while Athira Pharma’s (ATHA) share price is $0.29, making it a Buy.
Athira Pharma’s (ATHA) 100-Day exponential moving average is 0.50, while Athira Pharma’s (ATHA) share price is $0.29, making it a Sell.
Athira Pharma’s (ATHA) stock price is $0.29 and Athira Pharma’s (ATHA) 50-day simple moving average is 0.33, creating a Sell signal.
Athira Pharma’s (ATHA) stock price is $0.29 and Athira Pharma’s (ATHA) 100-day simple moving average is 0.45, creating a Sell signal.
Athira Pharma’s (ATHA) stock price is $0.29 and Athira Pharma’s (ATHA) 200-day simple moving average is 1.03, creating a Sell signal.

Athira Pharma (ATHA) Technical Indicators

Apr 25, 2025, 12:35 AM
Name
Value
Implied Action
RSI (14)
51.57
Neutral
STOCH (9,6)
81.27
Sell
STOCHRSI (14)
61.05
Neutral
MACD (12,26)
-0.02
Sell
ADX (14)
29.23
Neutral
Williams %R
-8.97
Sell
CCI (14)
55.76
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
65.82
Neutral
ROC
3.57
Buy
Athira Pharma’s (ATHA) Relative Strength Index (RSI) is 51.57, creating a Neutral signal.
Athira Pharma’s (ATHA) Trend Strength Indicator (ADX) is 29.23, creating a Neutral signal.
Athira Pharma’s (ATHA) Commodity Channel Index (CCI) is 55.76, creating a Neutral signal.
Athira Pharma’s (ATHA) Price Rate of Change (ROC) is 3.57, creating a Buy signal.

FAQ

Is ATHA a Buy, Hold, or Sell?
Based on ATHA’s technical indicators, ATHA is a Hold.
    What is ATHA’s RSI (14)?
    ATHA’s RSI (14) is 51.57, which suggests ATHA is a Neutral.
      What is ATHA’s MACD?
      ATHA’s MACD is -0.02, which suggests ATHA is a Sell.
        What is ATHA’s 5-day moving average?
        ATHA’s 5-day moving average is 0.26, which suggests ATHA is a Buy.
          What is ATHA’s 20-day moving average?
          ATHA 20-day moving average is 0.26, which suggests ATHA is a Buy.
            What is ATHA’s 50-day moving average?
            ATHA’s 50-day moving average is 0.33, which suggests ATHA is a Sell.
              What is ATHA’s 200-day moving average?
              ATHA’s 200-day moving average is 1.03, which suggests ATHA is a Sell.
                What is ATHA’s Williams % R (14)?
                ATHA’s Williams % R (14) is -8.97, which suggests ATHA is a Sell.
                  What is ATHA’s CCI (14)?
                  ATHA’s CCI (14) is 55.76, which suggests ATHA is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis